𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bevacizumab + irinotecan promising for patients with GBM

Book ID
120846464
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2007
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment with bevacizumab and irinoteca
Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors
✍ Felix Bokstein; Shulim Shpigel; Deborah T. Blumenthal πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 146 KB

## Abstract ## BACKGROUND Response rates to second‐line chemotherapy in recurrent high‐grade glial tumors are low and new effective treatments are needed. The objective of this study was to evaluate response rates and tolerability of chemotherapy with bevacizumab and irinotecan in recurrent high‐g